Published in Langenbecks Arch Surg on January 25, 2007
Mesenchymal stem cell therapy in patients with small bowel transplantation: single center experience. World J Gastroenterol (2014) 0.78
Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96
Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery (1968) 4.79
Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg (2003) 2.95
Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95
2003 report of the intestine transplant registry: a new era has dawned. Ann Surg (2005) 2.27
Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology (1995) 2.16
Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology (1999) 2.01
Serial transverse enteroplasty is associated with successful short-term outcomes in infants with short bowel syndrome. J Pediatr Surg (2005) 1.85
Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology (1997) 1.80
Quality of life in patients receiving home parenteral nutrition. Gut (1999) 1.71
Catheter-related infections associated with home parenteral nutrition and predictive factors for the need for catheter removal in their treatment. JPEN J Parenter Enteral Nutr (1994) 1.68
A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg (1995) 1.61
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation (1995) 1.59
AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology (2003) 1.58
Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol (2006) 1.49
Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management. Drug Saf (2001) 1.39
Intestinal transplantation: 1997 report of the international registry. Intestinal Transplant Registry. Transplantation (1999) 1.38
Segmental reversal of the small bowel as an alternative to intestinal transplantation in patients with short bowel syndrome. Ann Surg (1997) 1.28
Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant (2005) 1.26
Mortality and economics in short bowel syndrome. Best Pract Res Clin Gastroenterol (2003) 1.21
Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg (2005) 1.17
Experience with longitudinal intestinal lengthening and tailoring. Eur J Pediatr Surg (1999) 1.15
Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. J Pediatr Surg (1999) 1.14
Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. Mayo Clin Proc (1999) 1.09
Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. Transplant Proc (1994) 1.03
A schema for histologic grading of small intestine allograft acute rejection. Transplantation (2003) 1.02
Isolated intestinal transplantation: proof of clinical efficacy. Transplantation (2003) 1.00
Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: a possible evidence of acute humoral sensitization. Transplant Proc (2006) 0.98
Serial transverse enteroplasty enhances intestinal function in a model of short bowel syndrome. Ann Surg (2006) 0.97
Remaining small bowel length: association with catheter sepsis in patients receiving home total parenteral nutrition: evidence of bacterial translocation. World J Surg (2000) 0.96
Living-related intestinal transplantation: first report of a standardized surgical technique. Transplantation (1997) 0.94
Recurrent sepsis in home parenteral nutrition patients: an analysis of risk factors. JPEN J Parenter Enteral Nutr (1994) 0.93
Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil. Drugs (2005) 0.93
Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness. Transplant Proc (1999) 0.92
Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl (2003) 0.91
Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression. J Heart Lung Transplant (2004) 0.91
Focal cerebral deficits in severe hypomagnesemia. Pediatr Neurol (1992) 0.91
The contaminated small bowel syndrome: pathogenesis, diagnosis, and treatment. Am J Clin Nutr (1979) 0.91
Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children. Transplant Proc (1996) 0.91
Early referral is essential for successful pediatric small bowel transplantation: The Canadian experience. J Pediatr Surg (2001) 0.90
Clinical, social and rehabilitation status of long-term home parenteral nutrition patients: results of a European multicentre survey. Clin Nutr (2001) 0.90
The role of prophylactic cholecystectomy in the short-bowel syndrome. Arch Surg (1996) 0.90
Candidaemia in an Australian teaching hospital: relationship to central line and TPN use. J Infect (1998) 0.89
Quality of life after small intestinal transplantation and among home parenteral nutrition patients. JPEN J Parenter Enteral Nutr (1999) 0.88
Living related small bowel transplantation: donor surgical technique. Ann Surg (2004) 0.88
Surgical management of intestinal failure. Proc Nutr Soc (2003) 0.88
Segmental living related small bowel transplantation in adults. J Gastrointest Surg (2001) 0.88
Serious renal impairment is associated with long-term parenteral nutrition. JPEN J Parenter Enteral Nutr (1994) 0.88
Growth and nutritional status in infants with short-bowel syndrome after the serial transverse enteroplasty procedure. Clin Gastroenterol Hepatol (2006) 0.88
Classification, epidemiology and aetiology. Best Pract Res Clin Gastroenterol (2003) 0.87
Hypermanganesemia in patients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr (1999) 0.87
The first case report of the use of a zoom videoendoscope for the evaluation of small bowel graft mucosa in a human after intestinal transplantation. Gastrointest Endosc (1999) 0.87
Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol (2000) 0.86
Quality of life after pediatric intestinal transplantation: the perception of pediatric recipients and their parents. Am J Transplant (2004) 0.85
Severe convulsant hypomagnesaemia and short bowel syndrome. Anaesth Intensive Care (2001) 0.85
Intestinal transplantation before and after the introduction of sirolimus. Transplantation (2002) 0.83
Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study. J Bone Miner Res (2003) 0.83
Metabolic bone disease of total parenteral nutrition. Nutrition (1998) 0.83
Quality of life of patients after intestinal transplantation. Transplantation (1998) 0.83
Intestinal transplantation for gut failure. Gastroenterology (2003) 0.83
Surgical therapy for short bowel syndrome. Pediatr Surg Int (2004) 0.83
The medical management of intestinal failure: methods to reduce the severity. Proc Nutr Soc (2003) 0.82
Living related segmental bowel transplantation: from experimental to standardized procedure. Ann Surg (2006) 0.82
Mycophenolate mofetil as primary and rescue therapy in intestinal transplantation. Transplant Proc (1998) 0.80
Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients. Transplantation (2002) 0.80
Safety and efficacy of home parenteral nutrition for chronic intestinal failure: a 16-year experience at a single centre. Dig Liver Dis (2003) 0.79
The use of hormonal growth factors in the treatment of patients with short-bowel syndrome. Drugs (2006) 0.79
Evaluation of preservation conditions and various solutions for small bowel preservation. Transplantation (1994) 0.79
Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation. Transplantation (2004) 0.79
Basiliximab decreases the incidence of acute rejection after intestinal transplantation. Transplant Proc (2002) 0.78
Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation. Transplant Proc (2004) 0.78
The role of intestinal transplantation in the management of intestinal failure. Curr Gastroenterol Rep (2001) 0.77
The medical and surgical management of short bowel syndrome. MedGenMed (2004) 0.77
Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation. Transplantation (2003) 0.77
Effects of an isotonic oral rehydration solution, enriched with glutamine, on fluid and sodium absorption in patients with a short-bowel. Aliment Pharmacol Ther (1997) 0.77
Hepatobiliary, renal and bone complications of intestinal failure. Best Pract Res Clin Gastroenterol (2003) 0.76
IL-2 antagonists: the European perspective. Transplant Proc (2005) 0.76
Identification of early antigen BZLF1/ZEBRA protein of Epstein-Barr virus can predict the effectiveness of antiviral treatment in patients with post-transplant lymphoproliferative disease. Br J Haematol (2002) 0.76
Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide. Br J Haematol (2003) 0.76
Immunosuppression following intestinal transplantation. Transplant Proc (2004) 0.75
Metabolic bone disease in IBD. Curr Gastroenterol Rep (2000) 0.75
Renal dysfunction following adult intestinal transplant under tacrolimus-based immunosuppression. Transplant Proc (2006) 0.75
Goals of small bowel preservation. Transplant Proc (1996) 0.75
Management of venous access problems before and after intestinal transplantation: case reports. Transplant Proc (2004) 0.75
Hyaluronic acid and purine nucleoside phosphorylase in vascular and luminal effluents of small bowel grafts as parameters of preservation injury. Transplantation (1993) 0.75
Lymphoplasmacytic hyperplasia (possibly pre-PTLD) has varied expression and appearance in intestinal transplant recipients receiving Campath immunosuppression. Transplant Proc (2004) 0.75
Organ allocation for liver-intestine candidates. Liver Transpl (2004) 0.75
Functional liver recovery parallels autologous gut salvage in short bowel syndrome. J Pediatr Surg (2004) 0.75
Financial considerations insurance and coverage issues in intestinal transplantation. Prog Transplant (2004) 0.75
Acute renal failure and metabolic disturbances in the short bowel syndrome. QJM (2002) 0.75
Anastomotic ulceration following small bowel transplantation. Am J Transplant (2006) 0.75
Bacterial infections after intestine and multivisceral transplantation. The experience of the University of Miami (1994-2001). Hepatogastroenterology (2006) 0.75
Renal function and urinary excretion of electrolytes in patients receiving cyclic parenteral nutrition. JPEN J Parenter Enteral Nutr (2000) 0.75
Home parenteral nutrition in adults: the current use of an experienced method. Acta Gastroenterol Belg (1999) 0.75
International grading scheme for acute rejection in small bowel transplantation: implementation and experience at the University of Miami. Transplant Proc (2006) 0.75
Impact of the site of anastomosis after oncologic esophagectomy on quality of life--a prospective, longitudinal outcome study. Ann Surg Oncol (2007) 0.92
Small bowel cancer: single-centre results over a period of 12 years. Hepatogastroenterology (2007) 0.92
Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling. J Biol Chem (2003) 0.90
Revising the upper limit of normal for levels of serum alanine aminotransferase in a Middle Eastern population with normal liver histology. Dig Dis Sci (2013) 0.86
Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis. J Surg Res (2008) 0.84
Age- and gender-related differences of the immune function in a murine model of hemorrhagic shock: IL-10 restores immunodepression in aged females without reduction of mortality. Langenbecks Arch Surg (2007) 0.82
Influence of sex and age on morphological organ damage after hemorrhagic shock. Shock (2008) 0.81
Psychological strain in urgent indications for living donor liver transplantation. Liver Transpl (2007) 0.81
Wortmannin inhibits growth of human non-small-cell lung cancer in vitro and in vivo. Langenbecks Arch Surg (2002) 0.81
Recurrent deep-vein thrombosis based on homozygous factor V Leiden mutation acquired after liver transplantation. Liver Transpl (2003) 0.80
WOFIE stimulates regulatory T cells: a 2-year follow-up of renal transplant recipients. Transplantation (2006) 0.79
Invasive aspergillosis caused by Aspergillus terreus in a living donor liver transplant recipient successfully treated by caspofungin. Mycoses (2009) 0.78
Generation of monocyte-derived insulin-producing cells from non-human primates according to an optimized protocol for the generation of PCMO-derived insulin-producing cells. J Clin Res Pediatr Endocrinol (2014) 0.78
Investigation of the Lith6 candidate genes APOBEC1 and PPARG in human gallstone disease. Liver Int (2007) 0.78
Imaging of acute heart-transplant rejection using 99m-Technetium labelled oligonucleotides against interleukin-2 mRNA in rats. Eur J Cardiothorac Surg (2010) 0.76
Living donor liver transplantation in adults in the MELD era in Germany--a multi-center retrospective analysis. Transpl Int (2011) 0.76
Feasibility and early results of interstitial intensity-modulated HDR/PDR brachytherapy (IMBT) with/without complementary external-beam radiotherapy and extended surgery in recurrent pelvic colorectal cancer. Strahlenther Onkol (2005) 0.75
WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation. Transplantation (2003) 0.75
Liver transplant in Budd-Chiari syndrome: a single-center experience in Saudi Arabia. Exp Clin Transplant (2014) 0.75
Inferior Vena Cava Replacement in Living-Donor Liver Transplant for Hepatocellular Carcinoma: First Case Report in Saudi Arabia. Exp Clin Transplant (2017) 0.75
Psychosocial aspects of pediatric living donor liver transplantation. Liver Transpl (2006) 0.75
Low Utility of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Detecting Hepatocellular Carcinoma in Patients Before Liver Transplantation. Exp Clin Transplant (2017) 0.75
An analysis of outcomes of liver retransplant in adults: 12-year's single-center experience. Exp Clin Transplant (2015) 0.75
Treatment of Patients With Hepatitis C Virus infection (Genotype 4) With Ledipasvir-Sofosbuvir in the Liver Transplant Setting. Transplantation (2017) 0.75